AN OBSERVATIONAL STUDY TO EVALUATE THE POSTVACCINATION SYMPTOMS (COVAXIN) IN GENERAL POPULATION MORE THAN 18 YEARS OF AGE. CMN 2024, 6 (2), 720-731.